The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science.
The introduction of highly efficacious direct-acting antiviral (DAA) treatment therapeutics presents new opportunities to both directly reduce chronic hepatitis C virus (HCV) prevalence and prevent the onward transmission of HCV. To achieve the equitable scale-up of DAA interventions at the populati...
| Publicado en: | Canadian Journal of Public Health Vol. 110; no. 3; pp. 376 - 380 |
|---|---|
| Autores principales: | , |
| Formato: | research Journal Article |
| Publicado: |
Springer Nature
Jun2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |